Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults; [Análisis de costes y de coste/eficacia de las pautas recomendadas por GESIDA/Plan Nacional so
ISSN
0213005X
Date Issued
2018
Author(s)
DOI
10.1016/j.eimc.2017.04.002